08.14.2018Entasis Therapeutics Announces Positive Topline Results from Phase 2 Trial of ETX2514SUL in Patients with Complicated Urinary Tract Infections including Acute Pyelonephritis
08.09.2018AVROBIO, Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update
More News >